ResearchPrecision Frontiers in Hepatobiliary Oncology: Evaluating FGFR2 Selectivity and the Evolving Role of ImmunotherapyMarch 24, 2026By Gentry George Teng King, MD
ResearchDr. Emerson Y. Chen on Perioperative Chemoimmunotherapy and HER2-Directed Therapies in Resectable and Advanced Gastric Cancer
Cancer EducationDr. Julia Zhang on Challenging Treatment Dogma: Early Bispecific Antibody Use in Relapsed Myeloma